We are live on ! Find out more
CC

Callan Capital Portfolio holdings

AUM $1.35B
1-Year Est. Return 8.35%
This Fund
S&P 500
This Quarter Est. Return
+7.05%
1 Year Est. Return
+8.35%
3 Year Est. Return
+20.11%
5 Year Est. Return
+98.58%
10 Year Est. Return
+95.87%
AUM
$1.14B
AUM Growth
+$78M
Cap. Flow
+$4.03M
Cap. Flow %
0.35%
Top 10 Hldgs %
49.37%
Holding
304
New
70
Increased
124
Reduced
70
Closed
7

Top Buys

Rank Stock Value
1
AVUV icon
Avantis US Small Cap Value ETF
AVUV
+$3.94M
2
VTEB icon
Vanguard Tax-Exempt Bond Index Fund
VTEB
+$3.93M
3
NMRA icon
Neumora Therapeutics
NMRA
+$3.31M
4
VWO icon
Vanguard FTSE Emerging Markets ETF
VWO
+$2.97M
5
MSFT icon
Microsoft
MSFT
+$2.45M

Top Sells

Rank Stock Value
1
NVDA icon
NVIDIA
NVDA
+$16M
2
SCHB icon
Schwab US Broad Market ETF
SCHB
+$5.85M
3
JMST icon
JPMorgan Ultra-Short Municipal Income ETF
JMST
+$3.04M
4
SCHF icon
Schwab International Equity ETF
SCHF
+$2.44M
5
EW icon
Edwards Lifesciences
EW
+$2.12M

Sector Composition

Rank Sector Weight
1 Miscellaneous 86.4%
2 Technology 5.18%
3 Healthcare 2.32%
4 Financials 1.59%
5 Consumer Discretionary 1.18%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
PPL
201
PPL Corp
PPL
$25.7B
$309K 0.03%
+11,223
New +$299K
INGN icon
202
Inogen
INGN
$146M
$308K 0.03%
38,194
+17,583
+85% +$124K
MO icon
203
Altria Group
MO
$115B
$305K 0.03%
7,003
+1,748
+33% +$72.5K
VTI icon
204
Vanguard Morningstar Total Stock Market ETF
VTI
$687B
$304K 0.03%
1,171
– –
C icon
205
Citigroup
C
$223B
$304K 0.03%
+4,810
New +$268K
VOD icon
206
Vodafone
VOD
$37.1B
$303K 0.03%
34,056
+22,560
+196% +$196K
MRO
207
DELISTED
Marathon Oil Corporation
MRO
$298K 0.03%
+10,510
New +$254K
IDYA icon
208
IDEAYA Biosciences
IDYA
$3.87B
$295K 0.03%
6,726
– –
VUG icon
209
Vanguard Morningstar Growth ETF
VUG
$228B
$293K 0.03%
5,100
– –
AMG icon
210
Affiliated Managers Group
AMG
$9.59B
$292K 0.03%
+1,744
New +$271K
BBVA icon
211
Banco Bilbao Vizcaya Argentaria
BBVA
$160B
$292K 0.03%
24,637
+9,742
+65% +$97.4K
REGN icon
212
Regeneron Pharmaceuticals
REGN
$81.8B
$292K 0.03%
+303
New +$288K
TMO icon
213
Thermo Fisher Scientific
TMO
$230B
$287K 0.03%
+494
New +$277K
SCHW
214
Charles Schwab
SCHW
$191B
$282K 0.02%
3,901
+48
+1% +$3.16K
PM icon
215
Philip Morris
PM
$299B
$282K 0.02%
3,073
-133
-4% -$12.3K
RY icon
216
Royal Bank of Canada
RY
$283B
$281K 0.02%
2,784
-65
-2% -$6.42K
PYPL icon
217
PayPal
PYPL
$45.9B
$280K 0.02%
4,180
+220
+6% +$13.5K
WEC icon
218
WEC Energy
WEC
$34.6B
$279K 0.02%
3,396
+361
+12% +$29K
TLTD icon
219
Northern Trust Morningstar Developed Markets ex-US Factor Tilt ETF
TLTD
$690M
$277K 0.02%
3,871
+4
+0.1% +$274
AXP icon
220
American Express
AXP
$225B
$274K 0.02%
+1,204
New +$250K
RELX icon
221
RELX
RELX
$63.6B
$273K 0.02%
+6,308
New +$267K
GS icon
222
Goldman Sachs
GS
$301B
$273K 0.02%
+653
New +$253K
UL icon
223
Unilever
UL
$140B
$272K 0.02%
4,822
+695
+17% +$38.5K
BTI icon
224
British American Tobacco
BTI
$121B
$268K 0.02%
+8,777
New +$264K
DE icon
225
Deere & Co
DE
$170B
$266K 0.02%
647
+120
+23% +$46K
7 8
9
10 11

Similar funds

MBA
Maple-Brown Abbott Barangaroo, Australia $1.47B AUM 27.26% 1-Year Est. Return
SIA
Schechter Investment Advisors Birmingham, Michigan $1.21B AUM 8.73% 1-Year Est. Return
AP
Adero Partners Pleasanton, California $1.53B AUM 5.52% 1-Year Est. Return
MW
Marcum Wealth Cleveland, Ohio $1.16B AUM 6.7% 1-Year Est. Return
SBIA
Sheaff Brock Investment Advisors Indianapolis, Indiana $1.09B AUM 14.4% 1-Year Est. Return
LC
Lindbrook Capital Calabasas, California $1.08B AUM 10.14% 1-Year Est. Return
TW
Transform Wealth Greenwood Village, Colorado $1.65B AUM 19.1% 1-Year Est. Return
PAME
Parvus Asset Management Europe London, United Kingdom $1.67B AUM

Callan Capital's Q1 2024 Portfolio in Review

As of Q1 2024, Callan Capital held 304 positions worth $1.14B, up 7.4% from $1.06B the previous quarter. Its ten largest holdings account for 49% of the portfolio.

Callan Capital's Q1 2024 filing shows 70 new, 124 increased, 70 reduced and 7 closed positions. Its largest new stake was Neumora Therapeutics: 204,987 shares worth $2.82M. The largest sale was NVIDIA, an estimated $16M.

By sector, the portfolio is most concentrated in Miscellaneous at 86% of assets, down from 88% a quarter earlier, followed by Technology and Healthcare.

  • Callan Capital's largest Q1 2024 buy was Neumora Therapeutics: 204,987 shares worth $2.82M.
  • Callan Capital added most to Avantis US Small Cap Value ETF in Q1 2024, an estimated $3.94M increase.
  • Callan Capital's biggest Q1 2024 reduction was NVIDIA, cutting an estimated $16M.
  • Callan Capital fully exited Edwards Lifesciences in Q1 2024, selling an estimated $2.12M.
  • Callan Capital's ten largest holdings make up 49% of its $1.14B portfolio in Q1 2024.
  • Callan Capital opened 70 new positions and closed 7 in Q1 2024.
  • Callan Capital's portfolio value rose 7.4% quarter-over-quarter to $1.14B.

Based on Callan Capital's 13F filing for Q1 2024, filed 3 May 2024.